Amin Khalifa - Avivagen Insider

Avivagen Inc -- Canada Stock  

CAD 0.95  0.01  1.06%

Independent Director

Mr. Amin I. Khalifa is Independent Director of Avivagen Inc. He was Oct 2010 to present CFO Corporationrationrate Vice President, Iris International Inc., January 2008 to September 2010 Principal Khalifa Management Consulting, August 2006 to September 2007 Executive Vice President CFO Leap Wireless, August 2003 to August 2006 Executive Vice President CFO Apria Healthcare.
  Director Since 2011      

Management Efficiency

The company has return on total asset (ROA) of (57.97) % which means that it has lost $57.97 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (312.77) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 1.22 M in total debt with debt to equity ratio (D/E) of 45.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Avivagen Inc has Current Ratio of 5.93 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives


Michael McCainRoyal Bank of Canada
Kevin LynchCNOOC Limited
V YoungRoyal Bank of Canada
Harold MacKayThe Toronto Dominion Bank
Edward SonshineRoyal Bank of Canada
JeanRene HaldeThe Toronto Dominion Bank
William BeattieRoyal Bank of Canada
Karen MaidmentThe Toronto Dominion Bank
Bo LvCNOOC Limited
Alan MacGibbonThe Toronto Dominion Bank
Jacynthe CoteRoyal Bank of Canada
Andrew ChisholmRoyal Bank of Canada
Wei ChenCNOOC Limited
Thierry VandalRoyal Bank of Canada
Bridget KralingenRoyal Bank of Canada
Guangqi WuCNOOC Limited
Pedro ReinhardRoyal Bank of Canada
Mary HaddadThe Toronto Dominion Bank
Jeffery YabukiRoyal Bank of Canada
Wilbur PrezzanoThe Toronto Dominion Bank
John BraggThe Toronto Dominion Bank

Entity Summary

Avivagen, Inc. develops and commercializes various products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animals own health defenses. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen, Inc. in May 2012. Avivagen is traded on TSX Venture Exchange in Canada.Avivagen Inc (VIV) is traded on TSX Venture Exchange in Canada. It is located in 100 Sussex Drive and employs 19 people.

Did you try this?

Run Portfolio Manager Now

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
Hide  View All  NextLaunch Portfolio Manager

Fix Portfolio

Optimize Your Risk-Return Tradeoff
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Avivagen Inc to your portfolio

Top Management

Avivagen Inc Leadership Team
David Hankinson, Director
Louis Hui, Director
Chris Boland, CFO
David Allan, Director
Amin Khalifa, Director
Aubrey Dan, Director
Cameron Groome, CEO
Vanessa Grant, Director
Andrew Basek, Director, MBA
Drew Basek, Director, MBA
Paul Mesburis, Director
Graham Burton, Director, Ph.D
G Anthony, Director

Stock Performance

Avivagen Performance Indicators